Contineum Therapeutics Insider Trades

CTNM

Track insider trading activity from Contineum Therapeutics executives and directors. See which insiders are buying and selling CTNM stock.

Trades Last 12 Months

CTNM Price

All Insider Trades for Contineum Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lorrain Daniel S. Chief Scientific Officer
Holding Value $1.8M 143,842 shares
Last Trade
May 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$54.7k 4,170 shares
$13.12
$12.48
Watkins Tim CMO & Head Of Development
Holding Value $3.11M 249,167 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$55.4k 3,611 shares
$15.34
$12.48
Stengone Carmine N. CEO And President
Holding Value $220k 17,654 shares
Last Trade
Feb 25, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$42.6k 2,700 shares
$15.78
$12.48
Healy John Stephen General Counsel And Corp Sec
Holding Value $2.58M 206,411 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.94M 206,411 shares
$14.26
$12.48
Slover Peter T Chief Financial Officer
Holding Value $2.4M 192,000 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.74M 192,000 shares
$14.26
$12.48
Holding Value $184k 14,750 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.1k 14,750 shares
$4.01
$12.48
Ware Olivia C Director
Holding Value $184k 14,750 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.1k 14,750 shares
$4.01
$12.48
Holding Value $184k 14,750 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.1k 14,750 shares
$4.01
$12.48
Brady Todd R. Director
Holding Value $184k 14,750 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.1k 14,750 shares
$4.01
$12.48
Ignelzi Troy A. Director
Holding Value $184k 14,750 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.1k 14,750 shares
$4.01
$12.48
Boyce Sarah Director
Holding Value $184k 14,750 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.1k 14,750 shares
$4.01
$12.48
Holding Value $184k 14,750 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.1k 14,750 shares
$4.01
$12.48
Huhn Stephen L. CMO & Sr Vp, Clinical Dev.
Holding Value $1.37M 110,000 shares
Last Trade
Jan 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.08M 110,000 shares
$9.79
$12.48

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up